13 research outputs found

    Self-complexity and reactivity to social support receipt

    Get PDF
    While several studies have shown that support receipt in self-relevant domains may bring about increases in distress by delivering inefficacy cues to the recipient (e.g., Bolger & Amarel, 2007; Burke & Goren, under revision), results also indicate that some individuals are still able to experience benefits of support receipt in self-relevant domains (Burke & Perndorfer, in prep.). The purpose of the present research was to examine whether self-complexity, which has been shown to moderate the relationship between stress and health and well-being, moderates reactivity to support receipt in self-relevant domains. Study 1 (N = 77) attempted to expand past research on self-complexity by introducing measures of the purported cognitive mechanisms by which self-complexity results in affective consequences. Study 2 (N = 77) examined whether self-complexity moderates reactivity to support receipt in self-relevant domains. The results of the analyses did not support the hypothesis that participants low or high in self-complexity react differently to either failure feedback or support receipt in self-relevant domains. While the studies were unable to replicate past studies of self-complexity or provide support for self-complexity moderating reactivity to support receipt, we believe that the novel measures and modified procedures described in this research are contributions to both the self-complexity and social support literature

    Multi-modal Predictive Models of Diabetes Progression

    Full text link
    With the increasing availability of wearable devices, continuous monitoring of individuals' physiological and behavioral patterns has become significantly more accessible. Access to these continuous patterns about individuals' statuses offers an unprecedented opportunity for studying complex diseases and health conditions such as type 2 diabetes (T2D). T2D is a widely common chronic disease that its roots and progression patterns are not fully understood. Predicting the progression of T2D can inform timely and more effective interventions to prevent or manage the disease. In this study, we have used a dataset related to 63 patients with T2D that includes the data from two different types of wearable devices worn by the patients: continuous glucose monitoring (CGM) devices and activity trackers (ActiGraphs). Using this dataset, we created a model for predicting the levels of four major biomarkers related to T2D after a one-year period. We developed a wide and deep neural network and used the data from the demographic information, lab tests, and wearable sensors to create the model. The deep part of our method was developed based on the long short-term memory (LSTM) structure to process the time-series dataset collected by the wearables. In predicting the patterns of the four biomarkers, we have obtained a root mean square error of 1.67% for HBA1c, 6.22 mg/dl for HDL cholesterol, 10.46 mg/dl for LDL cholesterol, and 18.38 mg/dl for Triglyceride. Compared to existing models for studying T2D, our model offers a more comprehensive tool for combining a large variety of factors that contribute to the disease

    Fear of Cancer Recurrence and Inhibited Disclosure: Testing the Social-Cognitive Processing Model in Couples Coping With Breast Cancer

    No full text
    Over the first year of breast cancer survivorship, when patients or their intimate partners felt unable to share cancer-related concerns with one another, they reported higher levels of fear of cancer recurrence

    Psychosocial Impact of Cancer Care Disruptions in Women With Breast Cancer During the COVID-19 Pandemic

    No full text
    Background: The COVID-19 pandemic caused significant disruptions in cancer care, and preliminary research suggests that these disruptions are associated with increased levels of psychosocial distress among cancer survivors. The purpose of this study was to offer a descriptive report of the psychosocial functioning, perceived risk and fear of cancer progression, and COVID-19 pandemic impact and experiences in a unique, high-risk patient cohort: breast cancer survivors whose cancer treatment was delayed and/or changed due to the COVID-19 pandemic. Methods: This cross-sectional study included 50 women with dual carcinoma in situ, lobular carcinoma in situ, or invasive breast cancer whose cancer surgery was postponed due to the pandemic. As they awaited delayed surgery or shortly after they received delayed surgery, participants completed questionnaires on psychosocial functioning (depression, anxiety, sleep, and quality of life), their perceived risk and fear of cancer progression, patient-provider communication about disruptions in their care, personal impact of the pandemic, worry/threat about COVID-19, and COVID-19 symptoms/diagnoses. Descriptive statistics and bivariate correlations were computed among continuous study variables. Independent samples t-tests explored group differences in psychosocial functioning between survivors who were still awaiting delayed surgery and those who had recently received it. Results: Overall, the sample denied that the pandemic seriously negatively impacted their finances or resource access and reported low-to-moderate levels of psychosocial distress and fear about COVID-19. Twenty-six percent had clinically significant levels of fear of cancer progression, with levels comparable to other recent work. About a third were still awaiting delayed cancer surgery and this group reported lower satisfaction with communication from oncology providers but overall did not seem to report more psychosocial difficulties than those who already had surgery. Conclusion: Shortly before or after primary breast cancer surgery that was delayed due to the COVID-19 pandemic, this sample of survivors appears to be generally managing well psychosocially. However, many psychosocial difficulties (e.g., fear of cancer recurrence/progression) typically have an onset after the completion of treatment, therefore, research should continue to follow this cohort of cancer survivors as the pandemic's direct impact on their care likely increases their risk for these difficulties later in survivorship
    corecore